Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Focal Glomerulosclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT03949972
What this trial is testing

The FOrMe Registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry)

Who this might be right for
Glomerulosclerosis, Focal SegmentalMinimal Change DiseaseIdiopathic Nephrotic Syndrome
Prof. Dr. Paul Brinkkoetter 500
Large-scale testing (Phase 3)Study completedNCT01268033
What this trial is testing

Efficacy of Rituximab For the Treatment of Calcineurin Inhibitors Dependent Nephrotic Syndrome During Childhood

Who this might be right for
Childhood Idiopathic Nephrotic Syndrome
University Hospital, Limoges 26
Testing effectiveness (Phase 2)Study completedNCT00007475
What this trial is testing

Permeability Factor in Focal Segmental Glomerulosclerosis

Who this might be right for
Focal Segmental Glomerulosclerosis
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 15
Early research (Phase 1)Study completedNCT06529796
What this trial is testing

Evaluation of the Pharmacokinetics and Safety of Inaxaplin in Participants With Mild or Moderate Hepatic Impairment

Who this might be right for
Focal Segmental Glomerulosclerosis (FSGS)
Vertex Pharmaceuticals Incorporated 36
Not applicableLooking for participantsNCT02235857
What this trial is testing

Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children

Who this might be right for
Focal Segmental Glomerulosclerosis
Kaneka Medical America LLC 35
Very early researchStudy completedNCT03763643
What this trial is testing

PRI-VENT FSGS: Preemptive Rituximab to Prevent Recurrent Focal Segmental Glomerulosclerosis Post-Transplant

Who this might be right for
Focal Segmental Glomerulosclerosis
University of Minnesota 21
Not applicableStudy completedNCT00255398
What this trial is testing

Kidney Disease Biomarkers

Who this might be right for
Kidney DiseaseGlomerular DiseaseIdiopathic Nephrotic Syndrome+2 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 25
Testing effectiveness (Phase 2)Study completedNCT03649152
What this trial is testing

Safety and Effectiveness of Propagermanium in Focal Segmental Glomerulosclerosis Participants Receiving Irbesartan

Who this might be right for
Focal Segmental Glomerulosclerosis
Dimerix Bioscience Pty Ltd 8
Not applicableStudy completedNCT05200871
What this trial is testing

Humanistic Burden of (FSGS) Focal Segmental Glomerulosclerosis and IgAN (Immunoglobulin A Nephropathy)

Who this might be right for
Focal Segmental GlomerulosclerosisImmunoglobulin A Nephropathy
Travere Therapeutics, Inc. 487
Early research (Phase 1)Active Not RecruitingNCT06799520
What this trial is testing

Trial to Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of VIS171 in Participants With Autoimmune Disease(s)

Who this might be right for
Systemic Lupus Erythematosus (SLE)Alopecia Areata (AA)Immune-mediated Focal Segmental Glomerulosclerosis (FSGS)
Otsuka Pharmaceutical Development & Commercialization, Inc. 30
Not applicableLooking for participantsNCT05036850
What this trial is testing

China Kidney Patient Trials Network

Who this might be right for
Kidney Diseases
George (Beijing) Clinical Research Co. Ltd. 1,200
Early research (Phase 1)Study completedNCT05562362
What this trial is testing

Study to Evaluate the Pharmacokinetics of Oral Sparsentan Suspension

Who this might be right for
Healthy Subjects
Travere Therapeutics, Inc. 47
Testing effectiveness (Phase 2)Study completedNCT05237388
What this trial is testing

Janus Kinase-STAT Inhibition to Reduce APOL1 Associated Kidney Disease

Who this might be right for
Chronic Kidney Diseases
Duke University 8
Not applicableLooking for participantsNCT05583942
What this trial is testing

A Pilot Trial of taVNS for SRNS in Children (kidNEY-VNS)

Who this might be right for
Nephrotic Syndrome in ChildrenMinimal Change DiseaseFocal Segmental Glomerulosclerosis
Northwell Health 10
Testing effectiveness (Phase 2)Ended earlyNCT04950114
What this trial is testing

An Open-Label, Long-term Study of GFB-887 in Patients With Glomerular Kidney Diseases

Who this might be right for
Kidney DiseasesGlomerulosclerosisFocal Segmental Nephrosis+4 more
Goldfinch Bio, Inc. 31
Not applicableEnded earlyNCT00883636
What this trial is testing

Cardiomyopathy in Steroid-resistant Nephrotic Syndrome: Impact of Focal Segmental Glomerulosclerosis

Who this might be right for
Focal Segmental GlomerulosclerosisNephrotic SyndromeSteroid Resistant Nephrotic Syndrome+1 more
Northwell Health 4
Post-approval studies (Phase 4)Active Not RecruitingNCT07219121
What this trial is testing

Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental Glomerulosclerosis

Who this might be right for
ProteinuriaImmunoglobulin A (IgA) NephropathyFocal Segmental Glomerulosclerosis+1 more
Travere Therapeutics, Inc. 20
Not applicableLooking for participantsNCT06334692
What this trial is testing

Autoantibodies Against-nephrin in Idiopathic Nephrotic Syndrome

Who this might be right for
Nephrotic Syndrome
Mario Negri Institute for Pharmacological Research 100
Testing effectiveness (Phase 2)Study completedNCT03536754
What this trial is testing

CCX140-B in Subjects With FSGS

Who this might be right for
FSGSFocal Segmental GlomerulosclerosisGlomerulosclerosis
Amgen 46
Large-scale testing (Phase 3)Study completedNCT00135811
What this trial is testing

Focal Segmental Glomerulosclerosis Clinical Trial (FSGS-CT)

Who this might be right for
Glomerulosclerosis, Focal
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 192
Next Page